- Monitor patients regularly for the signs and symptoms of fluid retention.

- Monitor patients for signs and symptoms of cardiac or renal failure, especially in those with a history of cardiac disease or renal failure

- Monitor liver function (alkaline phosphatase, bilirubin, and transaminases) before starting treatment and then monthly afterward or as indicated going forward

- Monitor hepatic function

- Monitor TSH levels in patients after thyroidectomy

- Monitor growth in children

- Monitor patients with a high proliferative rate or high tumor burden for tumor lysis syndrome

- Monitor renal function before starting therapy and on an ongoing basis, especially in those with congestive heart failure, diabetes mellitus, or pre-existing renal impairment

- Monitor complete blood counts for evidence of hematologic toxicity (anemia, neutropenia, and thrombocytopenia)